Position in MGNX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$534,389
+$292,791 QoQ
Shares Held
184,910
+23.2% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PANAGORA ASSET MANAGEMENT INC holds $504,243,073 across 65 Biotechnology names. MGNX ranks #50 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,210,909 | $113,970,755 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105,225 | $81,301,044 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
742,117 | $55,109,608 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
461,193 | $28,916,801 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
143,499 | $27,128,485 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
351,370 | $23,938,838 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
592,912 | $17,615,415 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
57,320 | $17,022,320 |
All Filings in MGNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $534,389 | 184,910 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $241,598 | 150,061 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $102,816 | 61,200 | Shares | Sole | 2025-11-13 | |
| 2024-12-31 | $831,171 | 255,745 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,167,407 | 354,835 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,151,332 | 741,490 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $6,821,689 | 463,430 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,837,841 | 398,944 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,764,555 | 378,660 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,051,591 | 383,475 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,746,102 | 382,999 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,983,328 | 295,578 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $818,362 | 236,521 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $839,549 | 284,593 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,151,613 | 244,224 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,626,101 | 163,620 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,220,624 | 106,047 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $6,206,003 | 231,050 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $9,935,129 | 311,935 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $7,260,473 | 317,606 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,154,327 | 204,618 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,224,669 | 187,130 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $616,803 | 105,980 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||